X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ·Healthcare·Biotechnology
$3.08
-10.06%
Mkt Cap $337.67M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$11.67
Range $11.00 – $12.00
Implied Upside
+279.5%
Consensus $11.67 vs current $3.08
NASDAQ·Healthcare·Biotechnology
$3.08
-10.06%
Mkt Cap $337.67M
No recent rating data.
Price Target (10 analysts)
$11.67
Range $11.00 – $12.00
+279.5%
Consensus $11.67 vs current $3.08